The Cell Transplant Society is a section of the Transplantation Society the principal international forum for the advancement of basic and clinical transplantation science throughout the world. Scientific experts attending the meeting will report on the latest research findings in adult and embryonic stem cell biology; islet transplantation for diabetes; the potential for organ regeneration using adult stem cells; stem cells for treatment of Parkinson's disease and other neurodegenerative diseases, stroke and heart disease; gene therapy and stem cells in orthopaedics and cardiology; xenotransplantation; immune tolerance strategies for improving transplantation; regulatory issues; and clinical trials.
The meeting's organizing committee includes representatives from nine countries. The scientific program includes eleven plenary sessions, nine oral abstract sessions, a poster session, and a tribute to Paul E. Lacy, MD, PhD, retired chair of pathology at Washington University School of Medicine, who is recognized for developing the first experimental model for transplanting islet cells.
Collin Weber, MD, professor of surgery at Emory University School of Medicine and president of the Cell Transplant Society; William Wood, MD, Joseph B. Whitehead professor and chair of the Emory Department of Surgery; and Thomas Lawley, MD, dean of Emory School of Medicine, will open the conference presentations on Monday, March 3.
"These are extremely exciting times in the field of cell transplantation," Dr. Weber says, "not only because of the great p
Contact: Holly Korschun
Emory University Health Sciences Center